A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The presence of P+PBac{XP5.WH5}BSC808 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of the progenitor P{XP}d05044 to be Release 3 genomic coordinate 16110153 on chromosome arm 3R. This corresponds to Release 5 coordinate 3R:16110136 . The insertion site of the progenitor PBac{WH}CG6231f01139 is Release 5 coordinate 3R:15444823 . Consequently, the breakpoints of Df(3R)BSC808 predicted from the Release 5 genomic coordinates of the transposable element insertion sites are 3R:15444823 ; 3R:16110136 and the cytological breakpoints predicted from these coordinates are 92A11;92E1.